Latest Tariffs News

Medical Developments International returned to EBIT profitability in FY26 as Penthrox volumes strengthened across Australian hospitals and Europe. The company now faces the less glamorous test of converting regulatory progress into repeatable demand while absorbing weaker Respiratory sales and new amortisation costs.

City Chic Collective lifted FY26 underlying EBITDA 92% to $12.3 million despite a 3.1% revenue decline, helped by stronger ANZ trading, higher margins and a leaner cost base. The retailer remains loss-making after tax, but enters FY27 with $5.2 million in net cash and early signs of renewed store momentum.

GLG Corp has reported a sharp FY2026 reversal, with revenue falling 8.9% and a US$23.2 million net loss after a major impairment tied to outsourced manufacturer GLIT. The ASX-listed apparel group has since terminated the arrangement, secured bank covenant waivers and begun shifting production to Cambodia and Vietnam.

Atomos Limited (ASX:AMS) returned to profit in FY26 as revenue rose 22.5% and EBITDA swung positive, but the recovery remains financially fragile. The video technology group continues to carry negative net assets, used cash in operations and faces a possible covenant shortfall in the December half.

Gowing Bros’ FY2026 loss widened to $3.49 million as Surf Hardware International remained deeply loss-making and investment properties were marked down by $3.0 million. The ASX-listed investment company kept its fully franked final dividend at 3 cents per share, despite negative operating cash flow and lower cash reserves.

Compumedics Limited (ASX:CMP) returned to profit in FY26 as record revenue, stronger cash generation and a sharp rise in MEG and SaaS sales reshaped its earnings profile. The company enters FY27 with A$28.3 million of open orders, but lower gross margins and uneven US and European execution remain key tests.

Cettire returned to positive operating cash flow in FY26, but its annual report carries a material uncertainty over going concern after current liabilities exceeded current assets by A$51.8 million. The luxury e-commerce group also posted an A$8.5 million statutory loss and is relying on working-capital discipline, VAT recoveries and potentially conditional director support.

Delegat Group delivered record operating earnings and cash flow in FY26, but reported profit fell after a NZ$8.7 million impairment and other fair-value adjustments. The NZX-listed wine company is forecasting higher case sales and operating NPAT of NZ$62 million to NZ$66 million for FY27.

Ramsay Health Care delivered stronger FY26 earnings, a higher fully franked dividend and improved Funding Group leverage as it prepares to separate Ramsay Santé. The proposed demerger remains conditional, but the company has set a clear timetable for the next phase of its portfolio reshaping.

Waterco Limited (ASX:WAT) delivered record FY26 EBIT of $23.8 million and lifted net profit after tax 59.6% to $15.4 million, despite only modest revenue growth. The stronger result supports a higher fully franked dividend, but the group is carrying more debt and inventory as it expands manufacturing capacity.

Austco Healthcare delivered record FY26 revenue and statutory profit, with stronger margins, cash generation and a modest recovery in contracted orders entering the new financial year. The company is pairing that momentum with further reseller consolidation, including the $2.88 million acquisition of Medical Communications Systems.

Kingfish’s adjusted NAV rose 1.2% in August, broadly matching the NZX benchmark as Vista, Fisher & Paykel Healthcare and Delegat delivered the strongest portfolio gains. The fund still trades at a 7.5% discount to NAV, while its one-year shareholder return remains negative.